Vanguard Group
TGX

Vanguard Group’s THERAGENICS CORP TGX Stock Holding History

Vanguard Group’s Portfolio TGX Stock Details TGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-910,326
Closed -$1.98M – 3944
2013
Q3 		$1.98M Sell
910,326
-6,900
-0.8% -$14.7K ﹤0.01% 3133
2013
Q2 		$1.9M Buy
+917,226
New +$1.64M ﹤0.01% 3083

Vanguard Group's TGX Position: Q4 2013 in Review

Vanguard Group sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 910,326 shares — an estimated $1.98M sold.

Vanguard Group first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $1.98M in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • Vanguard Group reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • Vanguard Group sold 910,326 THERAGENICS CORP shares in Q4 2013, an estimated $1.98M.
  • Vanguard Group first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • Vanguard Group's THERAGENICS CORP position peaked at $1.98M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on Vanguard Group's 13F filing for Q4 2013, filed 12 Feb 2014.